Latest News for: wrn

Edit

Nimbus Therapeutics Announces Completion of Dose Escalation in Phase 1/2 Clinical Trial of NDI-219216, Novel WRN Inhibitor for MSI-H Tumors

Pharmiweb 19 Dec 2025
Pharmacokinetic and pharmacodynamic data indicated that NDI-219216 achieved robust WRN target engagement for more than 24 hours at multiple dose levels ... WRN is a DNA helicase required for DNA ...
Edit

WRN Inhibitors Market Enters Growth Phase with Multiple Early-Stage Clinical Programs Underway | DelveInsight

PR Newswire 12 Nov 2025
Discover which indication is expected to grab the major WRN inhibitors market share @ WRN Inhibitors Market Report ... Learn more about the WRN inhibitors @ WRN Inhibitors Analysis.
  • 1

Article Search

tools
×
×
×
×